Evaluation on efficacy of β-hemolytic Streptococcus iniae vaccine on olive flounder, Paralichthys olivaceus

β-용혈성 Streptococcus iniae 불활화백신의 넙치에 대한 효능 평가

  • Moon, Jin-San (National Veterinary Research and Quarantine Service, MAF) ;
  • Jang, Hwan (National Veterinary Research and Quarantine Service, MAF) ;
  • Kim, Ji-Yeon (National Veterinary Research and Quarantine Service, MAF) ;
  • Joh, Seong-Joon (National Veterinary Research and Quarantine Service, MAF) ;
  • Kim, Min-Jeong (National Veterinary Research and Quarantine Service, MAF) ;
  • Son, Seong-Wan (National Veterinary Research and Quarantine Service, MAF)
  • Accepted : 2007.08.30
  • Published : 2007.09.30


Olive flounder, Paralichthys olivaceus is one of the most important cultured fish in Korea, its farming has been negatively impacted by viral, bacterial and parasitic diseases. Streptococcal infection was considered as a serious problem because of significant economic losses in olive flounder farm industry. The development and evaluation of vaccine for protection against infection by this agent were required. We evaluated the safety and efficacy of ${\beta}$-hemolytic Streptococcus (S.) iniae vaccine on olive flounder Three hundreds of flounders (weight $119.8{\pm}20.7g$, body length $22.6{\pm}1.4cm$) were reared in 0.5 tons aquaria in land-marine tank system. Seawater was provided from the sea of Inchon in Korea, and water temperature was set to $22^{\circ}C$ and $25^{\circ}C$ in the vaccination and challenge test, respectively. We used the formalin-inactivated ${\beta}$-hemolytic S. iniae (F2K) vaccine (M VAC INIAE; Kyoritsu seiyaku, Japan) originated in Japan. The vaccine was intraperitoneally administered to fish. Both of vaccinated group and control group were challenged with intraperitoneally injection by virulent S. iniae SI-36 isolates with $1.0{\times}10^7CFU/fish$ at 3 weeks after vaccination. Difference on mortality of control and vaccinated group (90.0 and 15.0%, 76.5 and 8.0% respectively) at two trials were found significant (p<0.05), and relative percent survival were 83.4% and 89.5%, respectively. The dead fishes were showed dark pigmentation of skin, abdominal extension, hemorrhagic ascites, and liver necrosis, and isolated the S. iniae strain from ascites, liver and kidney. We confirmed the safety and efficacy of ${\beta}$-hemolytic S. iniae vaccine by determinations of the optimal management condition and artificial challenge test in olive flounder.


  1. 국립수산과학원 어류방역센터. 백신개발 현황. 2005
  2. 국립수의과학검역원. 국가검정동물용의약품 검정기준. 2006
  3. 이창훈, 하동수. 양식 넙치의 연쇄구균증. 한국어병학회지 1991, 4, 71-77
  4. 일본 농림수산성 동물의약품검사소. 동물용생물학적 제제 검정기준. 2007
  5. 일본 농림수산성. 일본에서의 어류백신 등록 현황 2005
  6. 전세규. 담수어의 연쇄구균증. 한국어병학회지 1989, 2, 31-35
  7. 정용욱, 강봉조, 박근태, 허문수. 16S-23S rRNA intergenic spacer region을 이용한 어류 병원성 Streptococcus iniae의 분자생물학적 동정. 한국어병학회지 2004, 17, 91-98
  8. 조미영, 이덕찬, 이주석, 도정완, 김명석, 최미영, 김이청, 강보규, 윤용덕, 김진우. 넙치에 대한 $\beta$-용혈성 연쇄구균 불활화백신의 안전성과 효능. 한국어병학회지 2006, 19, 165-172
  9. 조미영, 이주석, 이덕찬, 최희정, 검진우. $\beta$-용혈성 Streptococcus eaini 포르말린 불활화 사균 백신에 대한 넙치의 면역반응. 한국어병학회지 2006, 19, 73-82
  10. 中西照幸. 일본의 어병 대책과 백신개발 현황. 건강 어류 생산을 위한 어병 예방 및 치료 대책. pp. 167-185, 국립수산진흥원, 부산, 2000
  11. 한명국, 이오수, 김재홍. 닭 전염성후두기관염 생독백신의 안전성과 효능. 대한수의학회지 2002, 42, 241-251
  12. 해양수산부. 어업생산통계연보. 2005
  13. 허문수, 송춘복, 이제희, 여인규, 전유진, 이정재, 정상철, 이기완, 노섬, 최광식, 이영돈. 제주산 양식넙치 (Paralichthys olivaceus)로부터 분리된 $\beta$-용혈성 연쇄구균($\beta$-Streptococcus spp.)의 특성. 한수지 2001, 34, 365-369
  14. Bercovier H, Ghittino C, Eldar A. Immunization with bacterial antigens: infections with streptococci and related organisms. Dev Biol Stand 1997, 90, 153-160
  15. Domenech A, Fernandez-Garayzabal JF, Pascual C, Garcia JA, Cutuli MT, Moreno MA, Collins MD, Dominguez L. Streptococcosis in cultured turbot, Scophthalmus maximus (L.), associated with Streptococcus parauberis. J Fish Dis 1996, 19, 33-38 https://doi.org/10.1111/j.1365-2761.1996.tb00117.x
  16. Eldar A, Bejerano Y, Bercovier H. Streptococcus shiloi and streptococcus difficile: two new streptococcal species causing a meningoencephalitis in fish. Curr Microbiol 1994, 28, 139-143 https://doi.org/10.1007/BF01571054
  17. Eldar A, Ghittino C. Lactococcus garvieae and Streptococcus iniae infections in rainbow trout, Oncorhynchus mykiss: similar, but different diseases. Dis Aquat Organ 1999, 36, 227-231 https://doi.org/10.3354/dao036227
  18. Eldar A, Horovitcz A, Bercovier H. Development and efficacy of a vaccine against Streptococcus iniae infection in farmed rainbow trout. Vet Immunol Immunopathol 1997, 56, 175-183 https://doi.org/10.1016/S0165-2427(96)05738-8
  19. European Pharmacopoeia Commission. Vaccines. In: European Pharmacopoeia. vol. 5.0. 5th ed. 2005
  20. Finney DJ. Probit Analysis. 3rd ed. p. 333, Cambridge university Press, Cambridge, 1971
  21. Muzquiz JL, Royo FM. Ortega C. Bias ID, Ruiz I, Alonso JL. Pathogenicity of streptococcosis in rainbow trout (Oncorhynchus mykiss): dependence on age of diseased fish. Bull Eur Assoc Fish Pathol 1999, 19, 114-119
  22. Nakatsugawa T. A streptococcal disease of cultured flounder. Fish Pathol 1983, 17, 281-285 https://doi.org/10.3147/jsfp.17.281
  23. Office of the Federal Register National Archives and Records Administration. Code of Federal Regulations: Animal and Animal products. pp. 587-715, Washington, 2002